Elevance Health, Inc.
ELV
$289.10
$8.673.09%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.16% | 422.25% | -58.86% | -55.83% | 2.40% |
| Total Depreciation and Amortization | 1.88% | 211.01% | -202.13% | -1.79% | 1.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -39.43% | 367.39% | -202.22% | 138.63% | -159.90% |
| Change in Net Operating Assets | 87.79% | -9,816.67% | -101.45% | 163.53% | -97.87% |
| Cash from Operations | 101.97% | 44.05% | -73.63% | 498.88% | -77.40% |
| Capital Expenditure | -36.22% | 39.13% | 3.01% | -2.79% | -15.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | 99.64% |
| Divestitures | -200.00% | 111.11% | -- | -100.00% | -- |
| Other Investing Activities | -259.32% | -87.73% | 3,585.51% | 92.25% | 2.31% |
| Cash from Investing | -766.99% | 106.29% | -308.48% | 50.98% | 64.59% |
| Total Debt Issued | -68.78% | -83.40% | 10,393.75% | -96.41% | -14.34% |
| Total Debt Repaid | 108.06% | 5.93% | -155.46% | -630.84% | 118.26% |
| Issuance of Common Stock | -- | 43.75% | -66.67% | -20.00% | -38.14% |
| Repurchase of Common Stock | 70.39% | 44.71% | -2,648.48% | 85.75% | 30.48% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.26% | -3.49% | 1.32% | 0.00% | 0.26% |
| Other Financing Activities | 121.43% | -100.00% | -800.00% | -75.00% | 0.00% |
| Cash from Financing | 83.87% | -235.58% | 253.88% | -236.98% | 1,987.50% |
| Foreign Exchange rate Adjustments | 0.00% | 112.50% | -214.29% | 240.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -4,700.00% | 104.76% | -- |
| Net Change in Cash | 234.52% | -286.73% | -69.17% | 405.17% | 190.33% |